Piperidine → Methyl N-[(6-chloro-2-naphthyl)sulfonyl]-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}glycinate

HRID 1181003Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1181003
[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[CH:8]=[C:7]([S:12]([N:15]([CH2:27][C:28]([O:30][CH3:31])=[O:29])[C@H:16]1[CH2:20][CH2:19][N:18]([C@@H:21]([CH3:25])[C:22]([OH:24])=O)[C:17]1=[O:26])(=[O:14])=[O:13])[CH:6]=[CH:5]2.Cl.CN(C)CCCN=C=NCC.[CH:44]1[CH:45]=[CH:46]C2N(O)N=[N:50][C:48]=2[CH:49]=1.N1CCCCC1>C(Cl)Cl.C(N(CC)CC)C>[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[CH:8]=[C:7]([S:12]([N:15]([C@H:16]1[CH2:20][CH2:19][N:18]([C@@H:21]([CH3:25])[C:22](=[O:24])[N:50]3[CH2:46][CH2:45][CH2:44][CH2:49][CH2:48]3)[C:17]1=[O:26])[CH2:27][C:28]([O:30][CH3:31])=[O:29])(=[O:14])=[O:13])[CH:6]=[CH:5]2

Komponenten

7

Versuchsvorschrift

To a solution of (2S)-2-{(3S)-3-[[(6-chloro-2-naphthyl)sulfonyl](2-methoxy-2-oxoethyl)amino]-2-oxopyrrolidin-1-yl}propanoic acid (0.032 g) in DCM (5ml) were added 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (0.02 g), HOBT (0.014 g) and triethylamine (0.034 ml) and the mixture was stirred at room temperature for 1 h. Piperidine (0.01 ml) was added and the resultant mixture stirred at room temperature for 72 h. The mixture was concentrated under reduced pressure and the residue purified using mass directed preparative h.p.l.c. to give the title compound (0.017 g) as a white solid.

Aufarbeitung

  1. concentrationThe mixture was concentrated under reduced pressure
  2. customthe residue purified

Quellen und Nachweise

ORD-Eintrag
ord-2842e8d722ba48968a52cbf29f8f07fb
Quelldatensatz
uspto-grants-2007_10
Patentnummer
US07282497B2

Notizen zur Reaktion

Wird geladen…